Naproxen

Product NDC
68462-190
11-digit product format
684620190
Labeler code
68462
Product ID
68462-190_16372549-a419-4920-a200-5128017570ed
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Naproxen
Dosage form
TABLET
Route
ORAL
Labeler
Glenmark Pharmaceuticals Inc., USA
Application
ANDA078250
Marketing category
ANDA
Marketing start
2007-07-01
Substance
NAPROXEN
Active strength
500 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078250-001NAPROXENNAPROXEN250MGTABLET / ORALAB2007-03-28
A078250-002NAPROXENNAPROXEN375MGTABLET / ORALAB2007-03-28
A078250-003NAPROXENNAPROXEN500MGTABLET / ORALAB2007-03-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A078250-001AB
A078250-002AB
A078250-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-2831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-2831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-286a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-286a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-2803ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-2803ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-282680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-282680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-285bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-285bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28d06236e962d9…
2024-10-29 15:01 UTC2024-10A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28d06236e962d9…
2024-10-29 15:01 UTC2024-10A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-2879d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-2879d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-28301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-28301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-281e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-002NAPROXEN375MGTABLET / ORALAB2007-03-281e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-003NAPROXEN500MGTABLET / ORALAB2007-03-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078250-001NAPROXEN250MGTABLET / ORALAB2007-03-288072bd15b7f6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A078250-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078250-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078250-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078250-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A078250-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078250-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078250-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078250-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078250-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078250-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078250-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078250-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078250-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078250-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A078250-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A078250-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078250-003AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078250-003AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078250-003AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078250-001AB18072bd15b7f6…

Additional Listing Data#

Finished product
Yes
Brand name base
Naproxen
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NAPROXEN500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9TN87S3A3CInternal UNII lookup
57Y76R9ATQInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 5 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198012Internal RxNorm lookup
198013Internal RxNorm lookup
198014Internal RxNorm lookup
849398Internal RxNorm lookup
849431Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6c5bb008-e66f-4ef0-bf84-aca7eb5983e9Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68462-190-01Naproxen100 in 1 BOTTLETABLET10013
68462-190-05Naproxen500 in 1 BOTTLETABLET50013
68462-190-30Naproxen30 in 1 BOTTLETABLET3013
68462-190-50Naproxen50 in 1 BOTTLETABLET5013

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68462-190-01EA - Each68462-19055c7d22d-24b1-4caa-900d-a64686ffb2c812012-07-24
68462-190-05EA - Each68462-190faee55c5-faea-4267-9ea0-ec27e170e9dd12012-07-24
68462-190-30EA - Each68462-190c6456209-99c9-4dde-a2a8-08e6103b436312012-07-24
68462-190-50EA - Each68462-19087f20b4e-53b3-410e-9124-458e3bbba4a312012-07-24
68462-190-60EA - Each68462-190b65fdc4e-9f3c-45f2-b571-0d3b1eb3707912012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
.GAMMA.-AMINOBUTYRIC ACIDACTIVE INGREDIENT2ACZ6IPC6ITHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
NAPROXENACTIVE INGREDIENT57Y76R9ATQTHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
.GAMMA.-AMINOBUTYRIC ACIDACTIVE MOIETY2ACZ6IPC6ITHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
NAPROXENACTIVE MOIETY57Y76R9ATQTHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48THERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
GELATININACTIVE INGREDIENT2G86QN327LTHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30THERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DTHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
POVIDONEINACTIVE INGREDIENTFZ989GH94ETHERAPROXEN-500 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC]8
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET [PROFICIENT RX LP]4
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET [PROFICIENT RX LP]4
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET [PROFICIENT RX LP]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET [PROFICIENT RX LP]4
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675NAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WONAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET [PROFICIENT RX LP]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
POVIDONESINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET [PROFICIENT RX LP]4
POVIDONESINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPNAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]4
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET NAPROXEN SODIUM TABLET [STAT RX USA LLC]3
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET [DIRECT RX]2
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET [DIRECT RX]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET [DIRECT RX]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET [DIRECT RX]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET [DIRECT RX]2
POVIDONESINACTIVE INGREDIENTFZ989GH94ENAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET NAPROXEN SODIUM TABLET [BLENHEIM PHARMACAL, INC.]2
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]2
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CNAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UNAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4NAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET [CONTRACT PHARMACY SERVICES-PA]1
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET NAPROXEN SODIUM TABLET [ALTURA PHARMACEUTICALS, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68462-190NAPROXEN TABLET NAPROXEN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA]12Current NDC, Legacy NDC, 4 package rows20240814_6c5bb008-e66f-4ef0-bf84-aca7eb5983e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 25 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NaproxenNAPROXENUnit Dose Solutions, Inc.55652203-e5f3-78dc-e063-6294a90a3e462026-06-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENCoupler LLC545fe39a-4777-b149-e063-6394a90a53cf2026-06-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENCoupler LLC53e6519a-cb52-85e2-e063-6394a90abdcf2026-06-10Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENCoupler LLC52b8e52e-73be-3423-e063-6294a90af6e02026-05-26Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENBryant Ranch Prepack0041b483-34db-49a6-8665-f87e286cd0b82026-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutions4e97e645-552d-424b-990a-f94349a86f172026-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutions000155a8-709c-44e5-a75f-cd890f3a7caf2026-01-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutionsd06db628-f6f0-48e2-b538-69c0837c49e32026-01-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutions9d28422f-6f25-4f14-9272-e0907c971f332026-01-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENPreferred Pharmaceuticals Inc.87acd650-ea8a-4396-be72-5568c4b1755c2026-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
Naproxen SodiumNAPROXEN SODIUMGlenmark Pharmaceuticals Inc., USA6c5bb008-e66f-4ef0-bf84-aca7eb5983e92025-12-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
ndc (product): 68462-190
NaproxenNAPROXENAmerican Health Packaging86a3e612-3bfe-432f-9afd-972bb8a6644e2025-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutionse63a034d-23ef-458f-88ed-8b6d736996212025-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENPreferred Pharmaceuticals Inc.727913f6-9542-4a2d-9318-4b7ff521bffd2025-03-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENAdvanced Rx of Tennessee, LLCaf9aa7a0-e287-5935-e053-2995a90a1d112024-12-31Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENA-S Medication Solutionsbce23087-f055-4234-b75d-69dd432331902024-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENBryant Ranch Prepackda61463f-f87b-4aba-b538-7264252cadb82024-09-05Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENBryant Ranch Prepack1fe9a6fc-940e-4a18-b3e9-b204fd67f2632024-09-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENBoswell Pharmacy Services LLC d/b/a BPS Wholesale205b1159-06e5-0d48-e063-6294a90acbd82024-08-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250
NaproxenNAPROXENNuCare Pharmaceuticals, Inc.46dd3908-6feb-4f50-e054-00144ff88e882024-08-14Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 078250
application number: ANDA078250

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198012naproxen 375 MG Oral TabletPSNd06db628-f6f0-48e2-b538-69c0837c49e341
198014naproxen 500 MG Oral TabletPSNd06db628-f6f0-48e2-b538-69c0837c49e341
198012naproxen 375 MG Oral TabletSCDd06db628-f6f0-48e2-b538-69c0837c49e341
198014naproxen 500 MG Oral TabletSCDd06db628-f6f0-48e2-b538-69c0837c49e341
198012naproxen 375 MG Oral TabletPSN9d28422f-6f25-4f14-9272-e0907c971f3335
198014naproxen 500 MG Oral TabletPSN9d28422f-6f25-4f14-9272-e0907c971f3335
849431naproxen sodium 550 MG Oral TabletPSN9d28422f-6f25-4f14-9272-e0907c971f3335
198012naproxen 375 MG Oral TabletSCD9d28422f-6f25-4f14-9272-e0907c971f3335
198014naproxen 500 MG Oral TabletSCD9d28422f-6f25-4f14-9272-e0907c971f3335
849431naproxen sodium 550 MG Oral TabletSCD9d28422f-6f25-4f14-9272-e0907c971f3335
849431naproxen sodium 550 MG (as naproxen 500 MG) Oral TabletSY9d28422f-6f25-4f14-9272-e0907c971f3335
198014naproxen 500 MG Oral TabletPSN000155a8-709c-44e5-a75f-cd890f3a7caf31
198014naproxen 500 MG Oral TabletSCD000155a8-709c-44e5-a75f-cd890f3a7caf31
198013naproxen 250 MG Oral TabletPSN6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198012naproxen 375 MG Oral TabletPSN6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198014naproxen 500 MG Oral TabletPSN6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849398naproxen sodium 275 MG Oral TabletPSN6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849431naproxen sodium 550 MG Oral TabletPSN6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198013naproxen 250 MG Oral TabletSCD6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198012naproxen 375 MG Oral TabletSCD6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198014naproxen 500 MG Oral TabletSCD6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849398naproxen sodium 275 MG Oral TabletSCD6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849431naproxen sodium 550 MG Oral TabletSCD6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849398naproxen sodium 275 MG (as naproxen 250 MG) Oral TabletSY6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
849431naproxen sodium 550 MG (as naproxen 500 MG) Oral TabletSY6c5bb008-e66f-4ef0-bf84-aca7eb5983e913
198014naproxen 500 MG Oral TabletPSN96601d76-50ea-4dc0-b588-d174f8d8bb5111
198014naproxen 500 MG Oral TabletSCD96601d76-50ea-4dc0-b588-d174f8d8bb5111
198014naproxen 500 MG Oral TabletPSN701b69d8-cce8-42de-a770-96020c1a870a8
198014naproxen 500 MG Oral TabletSCD701b69d8-cce8-42de-a770-96020c1a870a8
198014naproxen 500 MG Oral TabletPSN3fdacbdf-15c4-6a44-e054-00144ff88e887
198014naproxen 500 MG Oral TabletSCD3fdacbdf-15c4-6a44-e054-00144ff88e887
198014naproxen 500 MG Oral TabletPSNaf9aa7a0-e287-5935-e053-2995a90a1d116
198014naproxen 500 MG Oral TabletSCDaf9aa7a0-e287-5935-e053-2995a90a1d116
198014naproxen 500 MG Oral TabletPSN86a3e612-3bfe-432f-9afd-972bb8a6644e5
198014naproxen 500 MG Oral TabletPSN27ab4f1a-2f2b-150c-e054-00144ff8d46c5
198014naproxen 500 MG Oral TabletPSN9f13f187-ed93-468a-92fb-1059dd409e575
198014naproxen 500 MG Oral TabletPSN3e8bcc59-dab1-1b4c-e054-00144ff88e885
198014naproxen 500 MG Oral TabletPSNd90378ef-c513-4471-a132-49720ac5d3a35
198014naproxen 500 MG Oral TabletSCD27ab4f1a-2f2b-150c-e054-00144ff8d46c5
198014naproxen 500 MG Oral TabletSCD9f13f187-ed93-468a-92fb-1059dd409e575
198014naproxen 500 MG Oral TabletSCD3e8bcc59-dab1-1b4c-e054-00144ff88e885
198014naproxen 500 MG Oral TabletSCD86a3e612-3bfe-432f-9afd-972bb8a6644e5
198014naproxen 500 MG Oral TabletSCDd90378ef-c513-4471-a132-49720ac5d3a35
198013naproxen 250 MG Oral TabletPSNc38ae25f-d73e-4f85-b450-87df87e989da4
198014naproxen 500 MG Oral TabletPSNc38ae25f-d73e-4f85-b450-87df87e989da4
198014naproxen 500 MG Oral TabletPSN4e97e645-552d-424b-990a-f94349a86f174
198014naproxen 500 MG Oral TabletPSN46dd3908-6feb-4f50-e054-00144ff88e884
198013naproxen 250 MG Oral TabletSCDc38ae25f-d73e-4f85-b450-87df87e989da4
198014naproxen 500 MG Oral TabletSCD46dd3908-6feb-4f50-e054-00144ff88e884
198014naproxen 500 MG Oral TabletSCD4e97e645-552d-424b-990a-f94349a86f174
198014naproxen 500 MG Oral TabletSCDc38ae25f-d73e-4f85-b450-87df87e989da4
198014naproxen 500 MG Oral TabletPSNa671b0fb-6b6b-43e7-994b-5de54582c4a73
198014naproxen 500 MG Oral TabletPSN686df0dd-42ac-4cd7-b838-51b172b06e0b3
198014naproxen 500 MG Oral TabletPSNada35c9d-a491-fd4d-e053-2995a90a53493
849431naproxen sodium 550 MG Oral TabletPSNa671b0fb-6b6b-43e7-994b-5de54582c4a73
198014naproxen 500 MG Oral TabletSCDada35c9d-a491-fd4d-e053-2995a90a53493
198014naproxen 500 MG Oral TabletSCDa671b0fb-6b6b-43e7-994b-5de54582c4a73
198014naproxen 500 MG Oral TabletSCD686df0dd-42ac-4cd7-b838-51b172b06e0b3
849431naproxen sodium 550 MG Oral TabletSCDa671b0fb-6b6b-43e7-994b-5de54582c4a73
849431naproxen sodium 550 MG (as naproxen 500 MG) Oral TabletSYa671b0fb-6b6b-43e7-994b-5de54582c4a73
198012naproxen 375 MG Oral TabletPSN50954ade-19ad-40dd-8e06-0b33394895f72
198014naproxen 500 MG Oral TabletPSN90b9ec56-d687-2746-e053-2995a90ae15a2
198014naproxen 500 MG Oral TabletPSN87acd650-ea8a-4396-be72-5568c4b1755c2
198014naproxen 500 MG Oral TabletPSN96aced89-fe07-439a-ac4c-59a0969993eb2
198014naproxen 500 MG Oral TabletPSN4f4083dc-54fe-109a-e054-00144ff88e882
198014naproxen 500 MG Oral TabletPSN65944dbd-d443-76d3-e053-2a91aa0ae69f2
198014naproxen 500 MG Oral TabletPSN50954ade-19ad-40dd-8e06-0b33394895f72
849398naproxen sodium 275 MG Oral TabletPSN50954ade-19ad-40dd-8e06-0b33394895f72
849431naproxen sodium 550 MG Oral TabletPSN50954ade-19ad-40dd-8e06-0b33394895f72
198012naproxen 375 MG Oral TabletSCD50954ade-19ad-40dd-8e06-0b33394895f72
198014naproxen 500 MG Oral TabletSCD4f4083dc-54fe-109a-e054-00144ff88e882
198014naproxen 500 MG Oral TabletSCD65944dbd-d443-76d3-e053-2a91aa0ae69f2
198014naproxen 500 MG Oral TabletSCD50954ade-19ad-40dd-8e06-0b33394895f72
198014naproxen 500 MG Oral TabletSCD87acd650-ea8a-4396-be72-5568c4b1755c2
198014naproxen 500 MG Oral TabletSCD96aced89-fe07-439a-ac4c-59a0969993eb2
198014naproxen 500 MG Oral TabletSCD90b9ec56-d687-2746-e053-2995a90ae15a2
849398naproxen sodium 275 MG Oral TabletSCD50954ade-19ad-40dd-8e06-0b33394895f72
849431naproxen sodium 550 MG Oral TabletSCD50954ade-19ad-40dd-8e06-0b33394895f72
849398naproxen sodium 275 MG (as naproxen 250 MG) Oral TabletSY50954ade-19ad-40dd-8e06-0b33394895f72
849431naproxen sodium 550 MG (as naproxen 500 MG) Oral TabletSY50954ade-19ad-40dd-8e06-0b33394895f72

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68462-190-0168462019001100 TABLET in 1 BOTTLE (68462-190-01) 100 tablet2007-07-010000-00-00NoNoCurrent
68462-190-0568462019005500 TABLET in 1 BOTTLE (68462-190-05) 500 tablet2007-07-010000-00-00NoNoCurrent
68462-190-306846201903030 TABLET in 1 BOTTLE (68462-190-30) 30 tablet2007-07-010000-00-00NoNoCurrent
68462-190-506846201905050 TABLET in 1 BOTTLE (68462-190-50) 50 tablet2007-07-010000-00-00NoNoCurrent